The evidence for Pramiracetam suggests it may enhance cognition and memory, particularly in individuals with cognitive impairment. However, the overall strength of the evidence is low, with limited clinical studies available. Most findings are based on pharmacological data rather than robust clinical trials.
PharmacokineticsNormal male volunteers · RCTModerate
Pramiracetam showed a peak plasma concentration between 2 to 3 hours post-administration with a half-life of 4.5 to 6.5 hours.
Cognitive enhancementIndividuals with cognitive impairment · Systematic reviewLow
Pramiracetam is suggested to enhance cognition & memory, though evidence is limited & primarily based on pharmacological properties.
Cognitive & Mood Support
Pramiracetam & phenylalanine are combined to support cognitive function & mood. Pramiracetam enhances memory & cognitive performance, while phenylalanine supports mood & cognitive function by acting as a precursor to neurotransmitters.
Forms & usage▾
Take 400-600 mg daily, ideally in the morning or early afternoon.